Cancer cells killed with their own carbon monoxide
- Details
- Category: Research
What if we could use a cancer’s own byproduct to make drugs that destroy tumor cells from the inside? That is exactly what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research Institute (PRI) in Japan. Published in Nature Communications, the proof-of-concept study describes how a synthetically designed compound uses the excess carbon monoxide produced in tumor cells to trigger the production of anti-cancer drugs within the cells themselves.
Can we stop antibiotic resistance in ruining promising drugs before they reach patients?
- Details
- Category: Research
What if we could predict in early development, which antibiotics bacteria are most likely to become resistant to? In a review published in Nature Reviews Microbiology, researchers from the HUN-REN Biological Research Centre, Szeged (HUN-REN BRC Szeged) and the Hungarian Centre of Excellence for Molecular Medicine (HCEMM) in Szeged propose a five-step decision-making framework that could help identify resistance risks early, refine promising drug candidates and prevent costly failures.
New therapeutic approach for the brain disorder SCA3
- Details
- Category: Research
Researchers from DZNE and the Hertie Institute for Clinical Brain Research (HIH) at the University of Tübingen, together with experts from Bonn, London, and Portugal, have developed and successfully tested in human neurons cultured in the lab a new approach for treating the rare neurodegenerative disease Spinocerebellar Ataxia Type 3 (SCA3).
Drug substance reduces blood vessel malformations in the brain
- Details
- Category: Research
Researchers have identified a substance that reduces blood vessel lesions in the brain in the disease Cerebral Cavernous Malformation (CCM). The substance is already used to treat brain tumours in children and could therefore relatively rapidly be repurposed to treat CCM, hopefully replacing surgery as the currently only treatment option.
Creating 'satellite maps' of proteins could transform drug therapies
- Details
- Category: Research
Much like a satellite provides a full picture of Earth, a ground-breaking new technology can generate thousands of detailed “satellite maps” showing where individual proteins are located and distributed across an entire tissue in the body or brain.
A University at Buffalo researcher has developed this novel technology, called hexagonal micro-scaffold assisted spatial proteomics (hex-MASP), which has the potential to transform how researchers study and create new drugs.
New AI platform helps uncover promising cancer drug combinations
- Details
- Category: Research
UCLA investigators have developed a new artificial intelligence-based platform that could help scientists identify promising drug combinations to overcome treatment resistance in cancer.
The platform, called MAESTRO and described in Advanced Science, uses large language models, or LLMs, to analyze scientific knowledge about how drugs work and the biological pathways cancer cells use to survive treatment.
AI aids in the development of new active ingredients
- Details
- Category: Research
Nature offers a virtually limitless variety of chemical substances. Although these have been optimized over millions of years of evolution for their respective purposes, they have not been optimized for use as active ingredients in humans. For decades, researchers have therefore been attempting to genetically reprogram microbial producers of active ingredients so that they produce variants of their natural compounds with improved pharmaceutical properties.
More Pharma News ...
- Transparent minispheres reveal that some look-alike cancer drugs part ways in 3D
- Researchers discover Achilles' heel of antibiotic-resistant bacteria
- Lactation drug could reduce breast cancer risk after childbirth
- Unsuspected discovery of abnormal antibodies could explain pediatric cancer
- How cancer cells lose dangerous DNA
- Nearly one billion people could live with osteoarthritis by 2050
- Pharmaceutical company marketing negatively influences prescribing